Mitigating risk in the gene therapy supply chainPublished: September 19, 2019
Supply Chain Focus: Biologistics Strategy for Scale-Up
Chad Presher is an Associate Director of Clinical Drug supply at Biogen. In this role Chad supports the clinical supply chains for Biogen’s Rare Disease Therapeutic Area. Prior to joining Biogen, Chad held commercial supply chain roles at Pfizer and Wyeth. Chad holds an MBA and a BS in Biology from the University of New Hampshire.DOI: 10.18609/cgti.2019.114
Citation: Cell & Gene Therapy Insights 2019; 5(9), 1069–1073.